Vioxx

Vioxx Research Studies

The following research studies and related summaries provide additional information about the adverse cardiovascular events linked to Vioxx use:

• The Cleveland Clinic, published in the Journal of the American Medical Association. Dr. Eric Topol, M.D., senior author of the report and chairman of the Department of Cardiovascular Medicine at The Cleveland Clinic.
• CIHR-funded research report from the Toronto's Institute of Clinical Evaluative Sciences published in the May 28, 2004 issue of The Lancet.
• FDA (U.S. Food and Drug Administration)-sponsored Kaiser Permanente Study of August 26, 2004.
• The VIGOR (Vioxx Gastrointestinal Outcomes Research) Summary of Patients with Cardiovascular Thrombotic Adverse Events noted in a Memo from the Project Manager of the Division of Anti-inflammatory Drug Projects.